U.S. Residents Novartis Oncology
4 Rare Diseases Go to Novartis Oncology
     

Dermatofibrosarcoma Protuberans

Diagnosis
DFSP initially presents as asymptomatic, indolent, indurated plaque or firm, irregular cutaneous nodule(s), varying in color from flesh to reddish brown and with a slow increase in size of the sarcoma. After several years, protuberant nodules develop within the plaque, and the growth rate increases. Approximately 25% of patients complain of ulceration, bleeding, or pain at the lesion site.1,2 The lesions most commonly occur on the trunk (50%-60%), followed by the proximal extremities (20%-30%), and the head and neck (10%-15%).1-3

Histologically, DFSP resembles a well-differentiated fibrosarcoma. In the plaque type of DFSP, slender tumor cells with large, spindle-shaped nuclei embed uniformly in the collagen stroma, parallel to the skin surface. Mitotic figures are sparse.3-5 In the nodular type, dense, uniform proliferation of fibroblastic tumor cells and irregular, short, intersecting bands of tumor cells form a storiform pattern. Also typical are cells radiating from a central hub of fibrous tissue, forming a cartwheel pattern.3

Macroscopic and microscopic presentation of DFSP.
Macroscopic and microscopic presentation of dermatofibrosarcoma protuberans (DFSP), solitary masses
Macroscopic and microscopic presentation of dermatofibrosarcoma protuberans (DFSP), ulceration
A. Solitary masses of subcutis and skin, average size 5 cm. B. May lead to ulceration of overlying skin with associated hemorrhage and cystic changes.
C. Cellular tumors of dermis and subcutis; slender fibroblasts in monotonous storiform pattern. D. Little pleomorphism with low to moderate mitotic activity.

From: www2.uic.edu/stud_orgs/prof/medclass2008/ pathslides/softtissuepathology.ppt - and http://www.uphs.upenn.edu/path/LabServices/cytowebcase/cyto014.html


References:
  1. Stojadinovic A, Karpoff HM, Antonescu CR, et al. Dermatofibrosarcoma protuberans of the head and neck. Ann Surg Oncol. 2000;7:696-704.
  2. McArthur G. Molecularly targeted treatment for dermatofibrosarcoma protuberans. Semin Oncol. 2004;31:30-36.
  3. Gloster HM, Jr. Dermatofibrosarcoma protuberans. J Am Acad Dermatol. 1996;35:355-374; quiz 375-376.
  4. Martin L, Piette F, Blanc P, et al. Clinical variants of the preprotuberant stage of dermatofibrosarcoma protuberans. Br J Dermatol. 2005;153:932-936.
  5. Sabater-Marco V, Perez-Valles A, Berzal-Cantalejo F, et al. Sclerosing dermatofibrosarcoma protuberans (DFSP): an unusual variant with focus on the histopathologic differential diagnosis. Int J Dermatol. 2006;45:59-62.
  Print This Page

Clinical trials

Rare Like Me

Disclaimer: This is an international website dedicated to rare diseases, and intended for healthcare professionals outside the US. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.
About Rare Diseases  |  DFSP  |  HES  |  Mast Cell Disease  |  Myelodysplastic / Myeloproliferative Diseases  |  Resources
Contact    |    Sitemap    |    Privacy
Use of this website is subject to our Terms of Use
©2009 Novartis AG